Phase 2CompletedAge-related condition

Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

Sponsor
Levicept (Industry)
Enrollment
518 enrolled
Conditions
Pain; Osteo Arthritis Knee; Knee Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases
Interventions
LEVI-04; Placebo
Ages
adults, older adults
Registry
NCT05618782

Full record on ClinicalTrials.gov

From the registry

This is a phase 2, randomized, double-blind, placebo-controlled trial of multiple doses and multiple administrations of LEVI-04 for the treatment of pain due to osteoarthritis of the knee.

Primary outcomes

  • Least Squares Mean Change From Baseline in WOMAC Pain

History

  1. Last registry update

  2. Results first posted

  3. Primary completion

  4. Registered

  5. Started

Papers citing this trial